-+ 0.00%
-+ 0.00%
-+ 0.00%
Olenox Industries Completes Acquisition Of PsyLinks Neurotech In Exchange For ~$500K Shares Of Restricted Common Stock Of Olenox
Share
Listen to the news

Acquisition adds applied artificial intelligence and data analytics capabilities to support Olenox's technology and digital infrastructure strategy
 

CONROE, TX / ACCESS Newswire / July 13, 2026 / Olenox Industries Inc. (NASDAQ:OLOX) ("Olenox" or the "Company"), a vertically integrated U.S. energy company, today announced the completion of its acquisition of PsyLinks Neurotech Corp. ("PsyLinks"), an applied intelligence company founded by neuroscientists Dr. Michael McLaren-Gradinaru and Dr. Ford Burles.

Under the terms of the Share Exchange Agreement, Olenox acquired all of the outstanding shares of PsyLinks in exchange for approximately $500,000 of shares of restricted common stock of Olenox. Psylinks will now operate as a wholly-owned subsidiary of Olenox. As part of the acquisition, Dr. Michael McLaren-Gradinaru and Dr. Ford Burles have joined Olenox as Vice President of Technology and Vice President of Product Development, respectively.

PsyLinks is a neurotechnology and applied intelligence company that develops technologies to collect, analyze, and interpret complex operational data. Olenox believes these capabilities complement its strategy of integrating energy production, industrial infrastructure, and digital technologies to enhance operational visibility, improve decision-making, and support future technology initiatives.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending